Literature DB >> 12630964

USH1C: a rare cause of USH1 in a non-Acadian population and a founder effect of the Acadian allele.

X M Ouyang1, J F Hejtmancik, S G Jacobson, X J Xia, A Li, L L Du, V Newton, M Kaiser, T Balkany, W E Nance, X-Z Liu.   

Abstract

Usher syndrome (USH) is characterized by the associated findings of hearing loss and retinitis pigmentosa (RP), leading to progressive loss of vision. Three forms of USH can be distinguished clinically. In the most severe form, USH1, profound congenital deafness is associated with vestibular dysfunction and RP. To determine the frequency of USH1C mutations as a cause for USH1, 128 probands with Usher syndrome type 1 including seven from Acadian and 121 from non-Acadian populations were systematically screened for mutations in USH1C using a combined single-strand conformational polymorphisms (SSCP)/heteroduplex and sequencing method. All seven Acadian USH1 patients were found to be homozygous for both the 216G>A mutation and the 9-repeat VNTR which characterizes the Acadian allele, confirming previous evidence for a founder effect by haplotype analysis. However, USH1C mutations were identified in only two non-Acadian USH1 probands (1.65%) including one from Pakistan who was homozygous for a 238-239insC mutation and one from Canada was also homozygous for the Acadian allele. The low prevalence of USH1C mutations in the present study suggests that the high prevalence of the 238-239insC in Germany may reflect a founder effect. Comparison of the affected haplotypes in the Canadian patient with the Acadian USH1 patients yielded evidence for a founder effect. Our data suggest that USH1C is a relatively rare form of USH1 in non-Acadian populations and that in addition to the 216G>A Acadian mutation, the 238-239insC mutation appears to be common in some populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12630964     DOI: 10.1046/j.0009-9163.2002.00004.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

Review 1.  Genetics and pathological mechanisms of Usher syndrome.

Authors:  Denise Yan; Xue Z Liu
Journal:  J Hum Genet       Date:  2010-04-09       Impact factor: 3.172

2.  Antisense oligonucleotide therapy rescues disruptions in organization of exploratory movements associated with Usher syndrome type 1C in mice.

Authors:  Tia N Donaldson; Kelsey T Jennings; Lucia A Cherep; Adam M McNeela; Frederic F Depreux; Francine M Jodelka; Michelle L Hastings; Douglas G Wallace
Journal:  Behav Brain Res       Date:  2017-10-14       Impact factor: 3.332

3.  High frequency of the p.R34X mutation in the TMC1 gene associated with nonsyndromic hearing loss is due to founder effects.

Authors:  Mariem Ben Saïd; Mounira Hmani-Aifa; Imen Amar; Shahid Mahmood Baig; Mirna Mustapha; Sedigheh Delmaghani; Abdelaziz Tlili; Abdelmonem Ghorbel; Hammadi Ayadi; Guy Van Camp; Richard J H Smith; Mustafa Tekin; Saber Masmoudi
Journal:  Genet Test Mol Biomarkers       Date:  2010-06

4.  Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population.

Authors:  Xiao Mei Ouyang; Denise Yan; Li Lin Du; J Fielding Hejtmancik; Samuel G Jacobson; Walter E Nance; An Ren Li; Simon Angeli; Muriel Kaiser; Valerie Newton; Steve D M Brown; Thomas Balkany; Xue Zhong Liu
Journal:  Hum Genet       Date:  2005-01-20       Impact factor: 4.132

5.  Transcriptomic Analyses of Inner Ear Sensory Epithelia in Zebrafish.

Authors:  Qi Yao; Lingyu Wang; Rahul Mittal; Denise Yan; Michael T Richmond; Steven Denyer; Teresa Requena; Kaili Liu; Gaurav K Varshney; Zhongmin Lu; Xue Zhong Liu
Journal:  Anat Rec (Hoboken)       Date:  2019-12-28       Impact factor: 2.064

6.  A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation.

Authors:  Tobias Goldmann; Nora Overlack; Fabian Möller; Valery Belakhov; Michiel van Wyk; Timor Baasov; Uwe Wolfrum; Kerstin Nagel-Wolfrum
Journal:  EMBO Mol Med       Date:  2012-10-02       Impact factor: 12.137

7.  An update on the genetics of usher syndrome.

Authors:  José M Millán; Elena Aller; Teresa Jaijo; Fiona Blanco-Kelly; Ascensión Gimenez-Pardo; Carmen Ayuso
Journal:  J Ophthalmol       Date:  2010-12-23       Impact factor: 1.909

8.  Novel mutations of MYO7A and USH1G in Israeli Arab families with Usher syndrome type 1.

Authors:  Leah Rizel; Christine Safieh; Stavit A Shalev; Eedy Mezer; Haneen Jabaly-Habib; Ziva Ben-Neriah; Elena Chervinsky; Daniel Briscoe; Tamar Ben-Yosef
Journal:  Mol Vis       Date:  2011-12-30       Impact factor: 2.367

9.  Deafblindness in French Canadians from Quebec: a predominant founder mutation in the USH1C gene provides the first genetic link with the Acadian population.

Authors:  Inga Ebermann; Irma Lopez; Maria Bitner-Glindzicz; Carolyn Brown; Robert Karel Koenekoop; Hanno Jörn Bolz
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness.

Authors:  Jennifer J Lentz; Francine M Jodelka; Anthony J Hinrich; Kate E McCaffrey; Hamilton E Farris; Matthew J Spalitta; Nicolas G Bazan; Dominik M Duelli; Frank Rigo; Michelle L Hastings
Journal:  Nat Med       Date:  2013-02-04       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.